Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

Lee WM, Dienstag JL, Lindsay KL, Lok AS, Bonkovsky HL, Shiffman ML, Everson GT, Di Bisceglie AM, Morgan TR, Ghany MG, Morishima C, Wright EC, Everhart JE; HALT-C Trial Group.

Control Clin Trials. 2004 Oct;25(5):472-92.

PMID:
15465617
2.

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.

3.

Spotlight on peginterferon-alpha-2a (40KD) in chronic hepatitis C.

Perry CM, Jarvis B.

BioDrugs. 2002;16(3):213-7. Review.

PMID:
12102649
4.
5.

Therapy of hepatitis C: from empiricism to eradication.

Pawlotsky JM.

Hepatology. 2006 Feb;43(2 Suppl 1):S207-20. Review.

PMID:
16447262
6.
7.

Nonresponders to hepatitis C virus antiviral therapy: pegylated interferons and beyond.

Fontana RJ.

Gastroenterol Clin North Am. 2004 Sep;33(3):527-47, viii. Review.

PMID:
15324942

Supplemental Content

Support Center